This page shows the latest Micro Labs news and features for those working in and with pharma, biotech and healthcare.
However, BMS is facing competition from generic rivals of Eliquis – in December 2019, the FDA approved the first two generics of the anticoagulant drug from Micro Labs and Mylan.
Sets stage for lower-cost competition to big-selling drug. The FDA has approved the first two generics of Pfizer and Bristol-Myers Squibb’s blockbuster anticoagulant drug Eliquis, from Micro ... The FDA has approved Micro Labs and Mylan’s generics to
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...